Discontinued — last reported Q3 '23

Business Segments · Charges

Other — Charges

Viatris Other — Charges decreased by 33.3% to $200.00K in Q3 2023 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ2 2023
Last reportedQ3 2023Nov 8, 2023

How to read this metric

An increase in these charges often indicates higher restructuring costs, legal settlements, or corporate overhead, which may negatively impact net income. A decrease suggests lower non-operational friction and potentially improved cost management.

Detailed definition

This metric represents non-recurring or miscellaneous expenses allocated to the 'Other' business segment, which typicall...

Peer comparison

Peers in the pharmaceutical industry often report similar items under 'unallocated corporate expenses' or 'restructuring and impairment charges', though the specific composition of 'Other' varies significantly by company structure.

Metric ID: vtrs_segment_other_charges

Historical Data

2 periods
 Q2 '23Q3 '23
Value$300.00K$200.00K
QoQ Change-33.3%
Range$200.00K$300.00K

Frequently Asked Questions

What is Viatris's other — charges?
Viatris (VTRS) reported other — charges of $200.00K in Q3 2023.
What does other — charges mean?
Miscellaneous or non-recurring costs that are not tied to the company's core business segments.